US Antimony Shares Sink After Q2 Print — Details Inside

Benzinga Earnings04:59

United States Antimony Inc. (AMEX:UAMY) posted its second-quarter results after Tuesday’s closing bell, missing estimates and lowering its revenue outlook.

Here’s a look at the key figures from the quarter.  

  • UAMY stock is moving. Watch the price action here.

United States Antimony Q2 Details       

United States Antimony reported quarterly earnings of zero cents, which missed the analyst consensus estimate of one cent, according to Benzinga Pro data.

Quarterly revenue of $7.925 million came in well below the Street estimate of $21.7 million and was down from $10.53 million in the same period last year.

U.S. Antimony reported the following quarterly highlights:

  • Antimony pounds sold up 26% in the quarter (exclusive of DLA)
  • Zeolite revenues grew 110% year-over-year
  • Antimony Inventory up 178% from year-end

“While our overall operations are continuing to improve markedly each month, those successes are only slowly trickling into our financial performance. While we made our first deliveries to the government during the second quarter, none of that achievement was reflected during this financial reporting period,” said CEO Gary C. Evans.

“We currently anticipate the third quarter should see a minimum of $9-$10 million of additional sales, all to the U.S. Government,” Evans added.

Read Also: Lumentum Beats Q4 Estimates: CEO Says Data Centers Turn Increasingly to Optical Links

Looking Ahead

U.S. Antimony slashed its fiscal 2026 revenue outlook in half: the company now expects revenue in a range of $60 million to $75 million, versus the $114.04 million estimate.

UAMY Stock Price Activity: According to data from Benzinga Pro, U.S. Antimony stock was down 14.44% to $5.63 in Tuesday’s extended trading.  

Photo: Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment